Streptococcus pneumoniae arginine synthesis genes promote growth and virulence in pneumococcal meningitis

Authors
  • J.R. Piet
  • M. Geldhoff
  • B.D.C. van Schaik
  • M.C. Brouwer
  • M. Valls Seron
  • M.E. Jakobs
  • K. Schipper
  • Y. Pannekoek
  • A.H. Zwinderman
  • T. van der Poll
  • A.H.C. van Kampen
  • F. Baas
  • A. van der Ende
  • D. van de Beek
Publication date 2014
Journal The Journal of Infectious Diseases
Volume | Issue number 209 | 11
Pages (from-to) 1781-1791
Organisations
  • Faculty of Science (FNWI) - Swammerdam Institute for Life Sciences (SILS)
  • Faculty of Medicine (AMC-UvA)
Abstract
Streptococcus pneumoniae (pneumococcus) is a major human pathogen causing pneumonia, sepsis and bacterial meningitis. Using a clinical phenotype based approach with bacterial whole-genome sequencing we identified pneumococcal arginine biosynthesis genes to be associated with outcome in patients with pneumococcal meningitis. Pneumococci harboring these genes show increased growth in human blood and cerebrospinal fluid (CSF). Mouse models of meningitis and pneumonia showed that pneumococcal strains without arginine biosynthesis genes were attenuated in growth or cleared, from lung, blood and CSF. Thus, S. pneumoniae arginine synthesis genes promote growth and virulence in invasive pneumococcal disease.
Document type Article
Note With supplementary data
Language English
Published at https://doi.org/10.1093/infdis/jit818
Permalink to this page
Back